How many insider declarations has Duran Felipe filed?

Duran Felipe has filed 3 public insider declarations with SEC (Form 4).

What is Duran Felipe's role?

Duran Felipe's reported role is not specified by the regulator across the filings.

Which companies does Duran Felipe report trades for?

Duran Felipe reports trades for iBio, Inc..

What is Duran Felipe's declared buy vs sell volume?

Across the available history, declared buys total 68k€ and disposals 0.

← Executives ★ Sign in to follow

DF

Duran Felipe

·SEC (Form 4)

iBio, Inc.

0

申报总数

0

公司

€68,005

▲ 买入（2 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

2

已披露卖出

0

T+90 胜率

0%

T+90 平均收益

-36.6%

基于 2 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。

信号历史

Explore the complete record of transactions filed by Duran Felipe. Officer active across 1 company, notably iBio, Inc.. Aggregated, 3 filings have been published. Split: 2 buys · 0 sell. Total volume traded: €68k. Activity tracked since 31 March 2023. The latest transaction was disclosed on 19 March 2026 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.

Companies and markets linked to Duran Felipe

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

iBio, Inc. (US)

申报3 总计

▲

Duran Felipe

Chief Financial Officer高管2026年3月19日iBio, Inc.

US$50,13241SEC ↗

24,835 股@ US$2.018664.3% 占其流量Common StockSEC:0001104659-26-033028:0

标准退出：2026年6月17日 (T+90)

▲

Duran Felipe

Chief Financial Officer高管2025年1月10日iBio, Inc.

US$25,00049SEC ↗

9,191 股@ US$2.72100.0% 占其流量Common StockSEC:0001104659-25-003064:0

标准退出：2025年4月10日 (T+90)

◆

Duran Felipe

Chief Financial Officer高管2023年3月31日iBio, Inc.

0SEC ↗

37,500 股0Common StockSEC:0001104659-23-040818:0

3 条申报中的 3 条

InsidersTradesSigma

← Executives ★ Sign in to follow

DF

Duran Felipe

·SEC (Form 4)

iBio, Inc.

0

申报总数

0

公司

€68,005

▲ 买入（2 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

2

已披露卖出

0

T+90 胜率

0%

T+90 平均收益

-36.6%

基于 2 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。

信号历史

Explore the complete record of transactions filed by Duran Felipe. Officer active across 1 company, notably iBio, Inc.. Aggregated, 3 filings have been published. Split: 2 buys · 0 sell. Total volume traded: €68k. Activity tracked since 31 March 2023. The latest transaction was disclosed on 19 March 2026 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.